Skip to main content
. Author manuscript; available in PMC: 2014 Nov 6.
Published in final edited form as: Curr Opin Infect Dis. 2013 Aug;26(4):326–331. doi: 10.1097/QCO.0b013e3283630c4c

Table 1.

Studies evaluating CDI in HSCT recipients, 2010 to present

Author (year) Study period HSCT type Patients Rate of CDI (%)
Leung (2010) [23] 2003–2007 Allo 26 26.9 (Allo)
Therriault (2010) [24] 2003–2008 Allo 231 3.5 (Allo)
Dubberke (2010) [25] 2001–2003 Allo 104 Not specified
Chopra (2011) [26] 2005–2006 Both 361 14.1 (Both); 18.1 (Allo); 8.3 (Auto)
Willems (2012) [27] 2004–2007 Allo 414 12.8 (Allo)
Alonso (2012) [28] 2003–2008 Both 999 9.2 (Both); 6.5 (Auto); 12.5 (Allo)
Kamboja (2012) [5▪] 2008–2009 Both 597 18.4 (Both); 9.0 (Auto); 27.0 (Allo)
Trifilio (2012) [29▪] 2004–2008 Both 822 10.3 (Both); 8.5 (Auto); 14.5 (Allo)
a

Data represent a subset of patients noted in the study from Memorial Sloan Kettering Cancer Center, 2008–2009. Overall rate of hospital-onset (HO)-CDI was 15.8 per 10 000 patient-days among patients with cancer across 11 U.S. centers.